Related Experiment Videos
T-cell responses in photoimmune therapy
1Dermatology Department, Yale University School of Medicine, New Haven, Connecticut, USA.
Journal of Clinical Apheresis
|January 1, 1995
Summary
Extracorporeal photoimmune therapy using ultraviolet A light and 8-methoxypsoralen shows promise for treating cutaneous T-cell lymphoma. This approach inactivates cells, potentially stimulating an immune response against the cancer.
Area of Science:
- Immunology
- Dermatology
- Phototherapy
Background:
- Cutaneous lymphoma is a significant dermatological condition.
- Existing treatments have limitations.
- Extracorporeal photopheresis (ECP) is a recognized therapy.
Purpose of the Study:
- To review the efficacy of extracorporeal inactivation using ultraviolet A light and 8-methoxypsoralen.
- To discuss the impact of this photoimmune therapy on T-cell responses in cutaneous lymphoma.
- To correlate findings from human studies with a mouse model.
Main Methods:
- Extracorporeal inactivation of lymphocyte-rich buffy coat suspension with ultraviolet A light and 8-methoxypsoralen.
- Reinfusion of treated cells.
- Analysis of immune responses in patients and a mouse model.
Main Results:
- Dramatic clinical improvements observed in patients with cutaneous lymphoma.
- Evidence of an active immune response against tumor cells in patients.
- Mouse model results parallel human clinical studies, supporting therapy impact on T-cell lymphoma.
Conclusions:
- Extracorporeal photoimmune therapy is a viable treatment for cutaneous lymphoma.
- The therapy appears to induce or enhance anti-tumor immune responses.
- Further investigation into the immunomodulatory effects is warranted.